Alcon (ALC) | Stock Overview & Key Data
Alcon Performance Comparison
Stock Range
Today's Range
Low: $86.78
High: $88.24
on August 15, 2025
52 Week Range
Low: $80.48
High: $101.10
on April 7, 2025
on September 12, 2024
All-Time High: $101.10 on September 9, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$45.8B
EPS
2.25
P/E Ratio (TTM)
40.84
Forward P/E
26.11
P/B Ratio
2.07
PEG Ratio
26.11
Div. Yield
N/A
ROE
5.23%
Beta
0.696
Debt to Equity
23.63
Financial Highlights
Profitability
Gross Margin
55.92%
Operating Margin
13.30%
Profit Margin
11.28%
Returns and Earnings
Return on Assets (TTM)
2.74%
Return on Equity (TTM)
5.23%
EBITDA
$1.5B
Net Income (TTM)
$1.1B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$20.07
Quarterly Revenue Growth (YoY)
0.60%
Quarterly Earnings Growth (YoY)
41.10%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Alcon ALC | 45.84B Large-cap | 2.29% | 2.05% | 0.05% | -1.95% | 5.10% | -7.32% | 27.36% | 49.65% |
| Intuitive Surgical ISRG | 172.16B Large-cap | 2.17% | -6.24% | -14.28% | -20.08% | -8.35% | 0.27% | 113.66% | 107.64% |
| Becton, Dickinson BDX | 56.16B Large-cap | 1.26% | 9.89% | 13.74% | -12.97% | -13.49% | -17.09% | -25.93% | -22.07% |
| ResMed RMD | 41.71B Large-cap | 0.35% | 13.05% | 14.61% | 23.55% | 24.69% | 25.09% | 22.01% | 58.83% |
| West Pharmaceutical WST | 17.70B Large-cap | 2.17% | 11.38% | 16.86% | 16.68% | -25.03% | -18.05% | -22.95% | -9.31% |
| Hologic HOLX | 15.08B Large-cap | -0.37% | 7.19% | 21.65% | 6.07% | -5.48% | -16.78% | -5.11% | 1.59% |
Ownership & Short Interest
Insider Ownership
0.13%
Institutional Ownership
68.80%
Shares Short
7M
Short Ratio
4.54
Short % of Shares Outstanding
N/A
Average 10-Day Volume
1M
Average 90-Day Volume
2M
Alcon Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Alcon would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALC's 52-week high and low?
- In the last 52 weeks, Alcon reached a high of $101.10 (on September 12, 2024) and a low of $80.48 (on April 7, 2025).
- What is the market cap and P/E ratio for ALC?
- Curious about Alcon's size and valuation? Its market capitalization stands at 45.84B. When it comes to valuation, the P/E ratio (trailing twelve months) is 40.84, and the forward P/E (looking ahead) is 26.11.
- Does ALC pay dividends? If so, what's the yield?
- As for dividends, Alcon isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Alcon's main competitors or similar companies to consider before investing?
When looking at Alcon, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG172.16B Healthcare Medical Instruments & Supplies 0.27% 113.66% Becton, Dickinson
BDX56.16B Healthcare Medical Instruments & Supplies -17.09% -25.93% ResMed
RMD41.71B Healthcare Medical Instruments & Supplies 25.09% 22.01% West Pharmaceutical
WST17.70B Healthcare Medical Instruments & Supplies -18.05% -22.95% Hologic
HOLX15.08B Healthcare Medical Instruments & Supplies -16.78% -5.11% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Alcon Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Alcon's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.23%, the Debt to Equity ratio from the most recent quarter is 23.63, and its Gross Profit Margin stands at 55.92%.
- What is the recent revenue and earnings growth for ALC?
- Looking at Alcon's growth, its revenue over the trailing twelve months (TTM) was $10B. Compared to the same quarter last year (YoY), quarterly revenue grew by 0.60%, and quarterly earnings saw a YoY growth of 41.10%.
- How much of ALC stock is held by insiders and institutions?
- Wondering who owns Alcon stock? Company insiders (like executives and directors) hold about 0.13% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 68.80%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.